Red blood cell distribution width as a predictor of cardiovascular outcomes in extensive aortoiliac disease

CONCLUSIONS: RDW is a widely available and low-cost marker that was able to independently predict long-term AHF, stroke, MACE, and all-cause mortality in patients with extensive aortoiliac disease submitted to revascularization. This biomarker could help assess which patients would likely benefit from stricter follow-up in the long-term.PMID:36168948 | DOI:10.23736/S0021-9509.22.12210-X

Source: The Journal of Cardiovascular Surgery - September 28, 2022 Category: Cardiovascular & Thoracic Surgery Authors: Nuno Vieira-Cardoso Ant ónio Pereira-Neves Mariana Frag ão-Marques Lu ís Duarte-Gamas Diogo Domingues-Monteiro Jos é Vidoedo Pedro Reis Jos é Teixeira Jos é P Andrade Jo ão Rocha-Neves Source Type: research